"Godi Media" Mixes Populism, Pro-BJP Propaganda - Reporters Sans Frontières
Serious threat to Press Freedom, India 159 in 180 countries
Source: thecitizen.in
Global Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Score Today - Breaking & Trending Today
Gantenerumab does not slow cognitive decline in early Alzheimer's
1. In these two randomized parallel-group trials, the use of gantenerumab did not lead to slower cognitive decline over 116 weeks among persons with early symptomatic Alzheimer’s disease compared to placebo. 2. After 116 weeks, gantenerumab was associated with lower amyloid plaque burden than the placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: The accumulation
Source: 2minutemedicine.com
GlobalData : reveals top 20 oncology influencers in Twitter during H1 2023
31 Jul, 2023 GlobalData reveals top 20 oncology influencers in Twitter during H1 2023 Share Print page ...
Source: marketscreener.com
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's Disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has announced that donanemab met all primary and secondary endpoints for the 6-month primary outcome analysis...
Source: prnewswire.com
Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's Disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has announced that donanemab met all primary and secondary endpoints for the 6-month primary outcome analysis...
Source: prnewswire.com